Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

NF1 Patients Receiving Breast Cancer Screening: Insights from The Ontario High Risk Breast Screening Program.

Maani N, Westergard S, Yang J, Scaranelo AM, Telesca S, Thain E, Schachter NF, McCuaig JM, Kim RH.

Cancers (Basel). 2019 May 22;11(5). pii: E707. doi: 10.3390/cancers11050707.

2.

Tamoxifen therapy in a murine model of myotubular myopathy.

Maani N, Sabha N, Rezai K, Ramani A, Groom L, Eltayeb N, Mavandadnejad F, Pang A, Russo G, Brudno M, Haucke V, Dirksen RT, Dowling JJ.

Nat Commun. 2018 Nov 19;9(1):4849. doi: 10.1038/s41467-018-07057-5.

3.

Dynamin 2 (DNM2) as Cause of, and Modifier for, Human Neuromuscular Disease.

Zhao M, Maani N, Dowling JJ.

Neurotherapeutics. 2018 Oct;15(4):966-975. doi: 10.1007/s13311-018-00686-0. Review.

Supplemental Content

Loading ...
Support Center